Description

Rigosertib treatment of head and neck squamous cell cancer

Publication Title

The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas.

Sample Metadata Fields

Specimen part, Cell line